DejaVueAI

DejaVueAI DejaVueAI DejaVueAI

DejaVueAI

DejaVueAI DejaVueAI DejaVueAI

AI-Assisted Prenatal System for Home & Remote Care—Anywhere. Anytime.

AI-Assisted Prenatal System for Home & Remote Care—Anywhere. Anytime.AI-Assisted Prenatal System for Home & Remote Care—Anywhere. Anytime.AI-Assisted Prenatal System for Home & Remote Care—Anywhere. Anytime.

How It Works

🧠 AI-Driven

🌐 Remote Monitoring

🧠 AI-Driven

  Real-Time Prenatal Scanning at Home 

🛠 Portable

🌐 Remote Monitoring

🧠 AI-Driven

 Portable Prenatal Device for Clinics, NGOs, and Moms 

🌐 Remote Monitoring

🌐 Remote Monitoring

🌐 Remote Monitoring

 AI Risk Detection for Improved Maternal Health 

Our Progress So Far

✅ Functional 3D prototype built

✅ AI-assisted module in development

✅ Functional 3D prototype built

✅ Clinics ready to pilot

✅ AI-assisted module in development

✅ Functional 3D prototype built

✅ AI-assisted module in development

✅ AI-assisted module in development

✅ AI-assisted module in development

✅ Founder capital invested

✅ Raising $300K for soft-launch

✅ AI-assisted module in development

✅ Raising $300K for soft-launch

✅ Raising $300K for soft-launch

✅ Raising $300K for soft-launch

------------60% to Beta Launch

Who It's For

 👩‍⚕️ Clinics & OB/GYNs | 👩 Expecting Women | 🌍 Underserved Populations | 🏥 Health NGOs 

What is DejaVue SUD+?

 DejaVue SUD+ bridges that gap with a safe, stigma-free solution that meets women where they are—at home, in care, or in recovery. 

DejaVue NeuroMat™

AI-Assisted Neuromuscular Diagnostic Platform for Pregnancy and Postpartum Care

Product Aims

  1. Prototype Finalization: Develop and verify  the clinical-grade NeuroMat™ system.
  2. Preclinical Safety Testing: Perform  biocompatibility, signal fidelity, and electrical safety assessments.
  3. Feasibility Trial: Conduct a 30-patient  IRB-approved clinical study to evaluate neuromuscular pattern detection.
  4. AI Model Validation: Refine diagnostic  algorithms using anonymized clinical data.
  5. Cloud Integration: Deploy clinician dashboard with HIPAA-compliant backend infrastructure.

Provisional Patent # 63/840479

 


Market & Opportunity

 

$7B+ Global Prenatal Market | 31,000+ Clinics in U.S. | 2,300+ Clinics in California

 

Capitalization Table

Pre-Money Valuation: $5M SAFE Note Terms: $250K for a projected 5% equity stake, with a 30% discount at the next priced round.

Projected ROI at Exit ($50M – $100M): 10–20x ROI potential driven by:

  • SaaS scalability
  • Neurology and maternal health market penetration
  • Strategic acquisition interest

 

Stay in the Loop

 Reach out to learn more about DejaVue’s AI ultrasound system, partnership opportunities, clinical pilots, or support for global maternal health. 

How It Works

Join the Beta for DejaVue Portable Prenatal System

Your support and contributions will enable us to meet our goals and fund our mission.

Pitch Deck Available Upon Request

Contact DejaVue | Partner, Pilot, or Support Our Mission

Reserve Your Spot – Help Us Bring Prenatal Innovation to Life

Copyright © 2025 DejaVueAI - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept